Variant · Snv
PSAP NM_002778.4(PSAP):c.1350+5G>T
CI-VAR-00362845Explore in graph →NM_002778.4:c.1350+5G>TClinVar 3597229
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3597229 | Uncertain significance | criteria provided, single submitter | 1 | Combined PSAP deficiency; Sphingolipid activator protein 1 deficiency; Gaucher disease due to saposin C deficiency; Parkinson disease 24, autosomal dominant, susceptibility to; Krabbe disease due to saposin A deficiency; Ovarian serous cystadenocarcinoma | germline | 2 | Jan 05, 2024 | clinvar |